Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sulindac placebo
DRUG
2 trials
Sponsors
M.D. Anderson Cancer Center
, Cancer Prevention Pharmaceuticals, Inc.
Conditions
Colorectal Cancer
Familial Adenomatous Polyposis
Phase 2
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
Terminated
NCT00062023
M.D. Anderson Cancer Center
Colorectal Cancer
Start: 2003-06-30
End: 2006-05-31
Updated: 2012-07-30
Phase 3
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Completed
NCT01483144
Cancer Prevention Pharmaceuticals, Inc.
Familial Adenomatous Polyposis
Start: 2013-10-31
End: 2019-03-31
Updated: 2021-06-08
Related Papers
Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial
Diseases of the Colon & Rectum
2021-07-15
17 citations
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
New England Journal of Medicine
2020-09-09
64 citations
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
2016-08-02
32 citations